Critically ill children can still undergo liver transplantation and survive

February 07, 2017

CHICAGO (Feb.7, 2017): Advancements in critical care make it possible for even the sickest children to successfully undergo liver transplantation. According to a new study published online as an "article in press" in the Journal of the American College of Surgeons (JACS), children who are sick enough to require mechanical ventilation or dialysis before transplantation achieve the same survival benefit as children who are stable prior to the surgical procedure. The study will appear in a print edition of the Journal this spring.

Since pediatric critical care was recognized as a specialty area of medicine in the 1980s-1990s, survival and disease recovery rates for acutely ill children have improved significantly. Pediatric intensive care units have reduced mortality rates for children with such life-threatening conditions as sepsis, cardiac arrest, and traumatic brain injury. Postoperative critical care systems have improved outcomes after many types of organ transplantation. These advances have increased survival of children with acute liver failure without transplantation and stabilized children with chronic liver failure who are on the wait list for transplantation.

In the present study, surgeons from Texas Children's Hospital and Baylor College of Medicine, Houston, found that pediatric critical care also has led to steady improvements in survival after liver transplantation regardless of the severity of illness of a child.

"Our study suggests that successful outcomes are now possible in the most critically ill patients with liver failure. Every effort should be made to transplant more children and sicker children," said John A. Goss, MD, FACS, professor of surgery, Michael E. DeBakey Department of Surgery and chief of the division of abdominal transplantation at Baylor.

The study is a nationwide evaluation of all children under the age of 18 years who had liver transplantation between 1987 and 2015. Although transplantations were performed in the 1960s, the study began gathering data from 1987 when the United Network for Organ Sharing (UNOS) first established measures for evaluating transplantation outcomes. The study divided data into two segments to compare outcomes of patients treated before and after 2002, when the Pediatric End-Stage Liver Disease system (PELD) was instituted. PELD is a method of scoring severity of liver disease on the basis of age, failure to grow, serum indicators of liver function, and an international normalized ratio. A similar set of data was gathered to reflect outcomes for children treated at Texas Children's Hospital.

Over the course of the study period, 13,723 children underwent liver transplantation across the country and were followed for an average of 6.6 years. A total of 4,248 of these children were in the ICU at the time of transplantation; these patients were followed for an average of 5.7 years. Between 2002 and 2015, 6,746 children had liver transplantation, 1,816 of whom were in the ICU at the time of the surgery.

Survival improved steadily for all patients over time. One-year survival was 66 percent in 1987 and 92 percent in 2015. Survival likewise improved for the sickest patients, as defined by the need for dialysis or mechanical ventilation. The one-year survival rate for patients on dialysis was 50 percent in 1995 and 95 percent in 2013; survival for patients on a ventilator was 49 percent in 1994 and 94 percent in 2013. The same survival benefit was seen in infants; the one-year survival rate increased from 45 percent in 1988 to 88 percent in 2013.

At Texas Children's Hospital, 65 of the 354 patients who had liver transplantation between 2002 and 2015 were ill enough to require admission to the ICU at the time of the operation. Survival at one year was 92 percent for the entire group and 87 percent for ICU patients.

An analysis of clinical and institutional risk factors that may affect survival showed that medical centers performing fewer than five transplants per year had poorer outcomes than high-volume centers.

"As critical care has improved and medical centers can keep seriously ill children alive longer, the question has evolved from can we perform a transplantation to should we do a transplant operation. The answer is yes, we can go ahead and transplant an organ into a critically ill child and expect the same outcome we would see in a stable child. The one caveat is if a medical center does not have the resources to perform a high volume of transplantations, then it should transfer critically ill children to a center that does," Dr. Goss said.
-end-
Other study participants were Abbas Rana, MD; Michael Kueht, MD; Moreshwar Desai, MBBS; Fong Lam, MD; Amir Miloh, MD; Jennifer Moffett, MD; N. Thao N. Galvan, MD, MPH; Ronald Cotton, MD; and Christine O'Mahony, MD.

The study was supported by the Cade R. Alpard Foundation. It was presented at the Southern Surgical Association 128th Annual Meeting, Palm Beach, FL, December 2016.

Citation: No Child Left Behind: Liver Transplantation in Critically Ill Children. Journal of the American College of Surgeons. DOI: http://dx.doi.org/10.1016/j.jamcollsurg.2016.12.025

About the American College of Surgeons

The American College of Surgeons is a scientific and educational organization of surgeons that was founded in 1913 to raise the standards of surgical practice and improve the quality of care for surgical patients. The College is dedicated to the ethical and competent practice of surgery. Its achievements have significantly influenced the course of scientific surgery in America and have established it as an important advocate for all surgical patients. The College has more than 80,000 members and is the largest organization of surgeons in the world. For more information, visit http://www.facs.org.

American College of Surgeons

Related Liver Disease Articles from Brightsurf:

Fatty liver disease despite a normal weight
Researchers from the University of Tsukuba found significant differences in the clinical presentation of non-obese patients with non-alcoholic fatty liver disease (NAFLD) based on their sex and body mass index.

Sobering reminder about liver disease
Alcohol's popularity and its central place in socialising in Australia obscures the dangers of excessive drinking and possible liver disease, Flinders University experts warn.

Giant leap in diagnosing liver disease
A collaborative team of Salk Institute and UC San Diego scientists have created a novel microbiome-based diagnostic tool that, with the accuracy of the best physicians, quickly and inexpensively identifies liver fibrosis and cirrhosis over 90 percent of the time in human patients.

Link between liver and heart disease could lead to new therapeutics
A newly published study of flies found that protecting liver function also preserves heart health.

Fatty liver disease is underdiagnosed in the US
According to an analysis published in Alimentary Pharmacology & Therapeutics, nonalcoholic fatty liver disease (NAFLD) is grossly underdiagnosed in the United States.

Possible new treatment strategy for fatty liver disease
Researchers at Karolinska Institutet in Sweden have identified a molecular pathway that when silenced could restore the normal function of immune cells in people with fatty liver disease.

Longevity protein SIRT6 also protects against fatty liver and fatty liver disease
SIRT6 regulates fat metabolism by activating another protein called peroxisome proliferator-activated receptor alpha (PPAR-alpha).

Fresh insights could lead to new treatments for liver disease
The fight against liver disease could be helped by the discovery of cells that cause liver scarring.

Better methods needed for predicting risk of liver disease
While blood samples can reliably identify people with a low risk of developing severe liver disease, better methods are needed in primary care for identifying people in most need of care.

Lab-on-a-chip may help identify new treatments for liver disease
Investigators have developed a 'lab on a chip' technology that can simulate different levels of non-alcoholic fatty liver disease progression.

Read More: Liver Disease News and Liver Disease Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.